A Pfizer Analysis Makes The Case For A COVID Vaccine Booster

The Food and Drug Administration released an analysis by Pfizer on the need for a booster shot of the Pfizer-BioNTech COVID-19 vaccine.

Pfizer's analysis says data from Israel and the United States in the context of the delta variant suggests "that vaccine protection against COVID-19 infection wanes approximately 6 to 8 months following the second dose."

The company said the available data supports its request for FDA approval of a third dose of the COVID-19 vaccine to be given about six months after the second dose in people 16 years and older.